Literature DB >> 6416544

Intestinal perforation associated with osmotic slow release indomethacin capsules.

T K Day.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6416544      PMCID： PMC1550156          DOI： 10.1136/bmj.287.6406.1671-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  The effect of wheat bran on intestinal transit.

Authors:  D K Payler; E W Pomare; K W Heaton; R F Harvey
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

2.  Ulceration and stricture of the jejunum in a patient on long-term indomethacin therapy.

Authors:  H F Sturges; C L Krone
Journal:  Am J Gastroenterol       Date:  1973-02       Impact factor: 10.864

3.  Indomethacin and perforated duodenal ulcer.

Authors:  M R Thompson
Journal:  Br Med J       Date:  1980-02-16

4.  An intestinal disease produced experimentally by a prostaglandin deficiency.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1975-10       Impact factor: 22.682

5.  Influence of indomethacin and of prostaglandin E1 on total and regional blood flow in man.

Authors:  J Nowak; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1978-04
  5 in total
  27 in total

1.  Non-steroidal anti-inflammatory drugs and perforated diverticular disease: a case-control study.

Authors:  H Goh; R Bourne
Journal:  Ann R Coll Surg Engl       Date:  2002-03       Impact factor: 1.891

Review 2.  Epidemiology of perforated colonic diverticular disease.

Authors:  C R Morris; I M Harvey; W S L Stebbings; C T M Speakman; H J Kennedy; A R Hart
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

3.  Small bowel enteroscopy in undiagnosed gastrointestinal blood loss.

Authors:  A J Morris; L A Wasson; J F MacKenzie
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 4.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Sigmoid diverticulitis perforation in burns: case reports and review of the literature.

Authors:  A Cirodde; P Jault; T Leclerc; N Donat; L Bargues
Journal:  Ann Burns Fire Disasters       Date:  2012-03-31

Review 6.  Non-steroidal anti-inflammatory drug-induced colitis.

Authors:  J L Faucheron; R Parc
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

7.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 8.  Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.

Authors:  R La Corte; M Caselli; G Castellino; G Bajocchi; F Trotta
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

9.  Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding.

Authors:  P J Prichard; T J Poniatowska; J E Willars; A T Ravenscroft; C J Hawkey
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

10.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

Authors:  C P Armstrong; A L Blower
Journal:  Gut       Date:  1987-05       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.